PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
05-Feb-2020 Phio Pharmaceuticals Announces $1.74 Million Registered Direct Offering Priced At-the-Market Phio Pharmaceuticals Corp.
05-Feb-2020 Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer Datar Cancer Genetics Ltd
05-Feb-2020 Concord Technologies Appoints Bill Shields to Board of Directors Concord Technologies
05-Feb-2020 R&D Leading to Supported Progress for Treating Acute Myeloid Leukemia (AML) Financialnewsmedia.com
05-Feb-2020 Neogen partners with ripe.io to bring blockchain to food safety and animal genomics Neogen Corporation
05-Feb-2020 RINVOQ(TM) (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis AbbVie
05-Feb-2020 Kineta Invited to Participate at the BIO CEO & Investor Conference Kineta, Inc.
05-Feb-2020 Aperiomics Expands Leadership Team with New Chief Operating Officer and Lead Clinical Laboratory Technologist Aperiomics
05-Feb-2020 Obsidian Therapeutics Announces Formation of Scientific Advisory Board Obsidian Therapeutics
05-Feb-2020 DelMar Pharmaceuticals to Attend the 22nd Annual BIO CEO & Investor Conference in New York City February 10 and 11, 2020 DelMar Pharmaceuticals, Inc.
05-Feb-2020 DelMar Pharmaceuticals to Attend the 22nd Annual BIO CEO & Investor Conference in New York City February 10 and 11, 2020 DelMar Pharmaceuticals, Inc.
05-Feb-2020 DelMar Pharmaceuticals to Attend the 22nd Annual BIO CEO & Investor Conference in New York City February 10 and 11, 2020 DelMar Pharmaceuticals, Inc.
05-Feb-2020 Kymera Therapeutics to Present Preclinical Data on its First-in-Class Selective and Potent Oral IRAK4 Degraders in Cutaneous Inflammation Kymera Therapeutics Inc.
05-Feb-2020 Kymera Therapeutics to Present Preclinical Data on its First-in-Class Selective and Potent Oral IRAK4 Degraders in Cutaneous Inflammation Kymera Therapeutics Inc.
05-Feb-2020 ProDigest and CosmosID Launch the 'Gut Microbiome Therapeutic Innovation' Challenge CosmosID
05-Feb-2020 CytoSorb Used Successfully to Help Treat Grade 4 Cytokine Release Syndrome Following CAR T-cell Immunotherapy in First Published Case Report CytoSorbents Corporation
05-Feb-2020 CytoSorb Used Successfully to Help Treat Grade 4 Cytokine Release Syndrome Following CAR T-cell Immunotherapy in First Published Case Report CytoSorbents Corporation
05-Feb-2020 Ichnos Expands Leadership Team With Appointment Of Gabriela Gruia, M.D. As Chief Development Officer Ichnos Sciences
05-Feb-2020 Ichnos Expands Leadership Team With Appointment Of Gabriela Gruia, M.D. As Chief Development Officer Ichnos Sciences
05-Feb-2020 Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development Sutro Biopharma